Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0139
-0.0001 (-0.71%)
At close: Jan 30, 2026
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $975.62 thousand as of January 30, 2026. Its market cap has decreased by -83.41% in one year.
Market Cap
975.62K
Enterprise Value
32.37M
Revenue
11.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 975.62K, a decrease of -99.72%. That is a compound annual growth rate of -59.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 975.62K | 17.51% |
| Dec 31, 2025 | 830.25K | 52.94% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZyVersa Therapeutics | 1.30M |
| Halberd | 1.20M |
| CERo Therapeutics Holdings | 1.19M |
| International Stem Cell | 1.12M |
| Evofem Biosciences | 1.11M |
| Sigyn Therapeutics | 987.19K |
| Protagenic Therapeutics | 918.45K |
| Eastgate Biotech | 846.29K |